The Kids Research Institute Australia logo
Donate

Discover Prevent Cure

Advances in Automated Insulin Delivery with the Medtronic 780G: The Australian Experience

To assess the real-world performance of MiniMed™ 780G for Australians with type 1 diabetes (T1D) following advanced hybrid closed loop (AHCL) activation and to evaluate the effect of changing from MiniMed 670/770G to 780G.

Citation:
Halim B, Abraham MB, Manos G, Arrieta A, ……. Davis EA, Jenkins A, ……. Jones TW, O’Neal D. Advances in Automated Insulin Delivery with the Medtronic 780G: The Australian Experience. Diabetes Technol Ther. 2024;26(3):190-7.

Keywords:
Automated insulin delivery; Closed loop insulin delivery; Glucose control; Hyperglycemia; Hypoglycemia; Real-world evidence; Type 1 diabetes.

Abstract:
To assess the real-world performance of MiniMed™ 780G for Australians with type 1 diabetes (T1D) following advanced hybrid closed loop (AHCL) activation and to evaluate the effect of changing from MiniMed 670/770G to 780G.